Zurn Water Solutions Corporation
Get $10 bonus on your first $100 deposit for RXN
Get $10 bonus on your first $100 deposit for RXN
Zurn Water Solutions Corporation (RXN) Stock Competitors & Peer Comparison
See (RXN) competitors and their performances in Stock Market.
Peer Comparison Table: Regulated Water Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RXN | $64.95 | +0.90% | 11.4B | N/A | N/A | +0.54% |
| AWK | $133.39 | -0.76% | 26.1B | 23.45 | $5.69 | +2.49% |
| SBS | $33.80 | +0.36% | 23.8B | 13.97 | $2.42 | +3.64% |
| WTRG | $39.47 | -0.30% | 11.2B | 17.95 | $2.20 | +3.43% |
| AWR | $75.86 | +0.56% | 3B | 22.52 | $3.37 | +2.62% |
| CWT | $45.13 | +0.04% | 2.7B | 20.99 | $2.15 | +2.74% |
| HTO | $58.10 | -0.19% | 2B | 19.90 | $2.92 | +2.92% |
| SJW | $54.86 | -0.67% | 1.9B | 18.29 | $3.00 | +0.77% |
| CDZIP | $19.28 | -0.52% | 1.6B | -23.27 | -$0.83 | N/A |
| WTTR | $14.81 | +2.21% | 1.6B | 70.52 | $0.21 | +1.91% |
Stock Comparison
RXN vs AWK Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWK has a market cap of 26.1B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $133.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 23.45. In terms of profitability, RXN's ROE is +0.13%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to AWK. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWK's competition here
RXN vs SBS Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SBS has a market cap of 23.8B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 13.97. In terms of profitability, RXN's ROE is +0.13%, compared to SBS's ROE of +0.20%. Regarding short-term risk, RXN is more volatile compared to SBS. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check SBS's competition here
RXN vs WTRG Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRG has a market cap of 11.2B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $39.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 17.95. In terms of profitability, RXN's ROE is +0.13%, compared to WTRG's ROE of +0.09%. Regarding short-term risk, RXN is more volatile compared to WTRG. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check WTRG's competition here
RXN vs AWR Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWR has a market cap of 3B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $75.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 22.52. In terms of profitability, RXN's ROE is +0.13%, compared to AWR's ROE of +0.13%. Regarding short-term risk, RXN is more volatile compared to AWR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWR's competition here
RXN vs CWT Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWT has a market cap of 2.7B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $45.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 20.99. In terms of profitability, RXN's ROE is +0.13%, compared to CWT's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to CWT. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWT's competition here
RXN vs HTO Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, HTO has a market cap of 2B. Regarding current trading prices, RXN is priced at $64.95, while HTO trades at $58.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas HTO's P/E ratio is 19.90. In terms of profitability, RXN's ROE is +0.13%, compared to HTO's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to HTO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check HTO's competition here
RXN vs SJW Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SJW has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.29. In terms of profitability, RXN's ROE is +0.13%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SJW's competition here
RXN vs CDZIP Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZIP has a market cap of 1.6B. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -23.27. In terms of profitability, RXN's ROE is +0.13%, compared to CDZIP's ROE of -1.05%. Regarding short-term risk, RXN is more volatile compared to CDZIP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CDZIP's competition here
RXN vs WTTR Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTTR has a market cap of 1.6B. Regarding current trading prices, RXN is priced at $64.95, while WTTR trades at $14.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTTR's P/E ratio is 70.52. In terms of profitability, RXN's ROE is +0.13%, compared to WTTR's ROE of +0.03%. Regarding short-term risk, RXN is less volatile compared to WTTR. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTTR's competition here
RXN vs MSEX Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, MSEX has a market cap of 960.5M. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $51.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 21.97. In terms of profitability, RXN's ROE is +0.13%, compared to MSEX's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to MSEX. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check MSEX's competition here
RXN vs CWCO Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWCO has a market cap of 543.9M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $34.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 28.63. In terms of profitability, RXN's ROE is +0.13%, compared to CWCO's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to CWCO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWCO's competition here
RXN vs YORW Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, YORW has a market cap of 454.4M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $31.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 22.63. In terms of profitability, RXN's ROE is +0.13%, compared to YORW's ROE of +0.08%. Regarding short-term risk, RXN is more volatile compared to YORW. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check YORW's competition here
RXN vs CDZI Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZI has a market cap of 391.3M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -9.77. In terms of profitability, RXN's ROE is +0.13%, compared to CDZI's ROE of -1.05%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZI's competition here
RXN vs ARTNA Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARTNA has a market cap of 335.9M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $32.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 14.77. In terms of profitability, RXN's ROE is +0.13%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to ARTNA. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check ARTNA's competition here
RXN vs VWTR Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, VWTR has a market cap of 288.2M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.13%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check VWTR's competition here
RXN vs PCYO Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, PCYO has a market cap of 272.4M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 19.82. In terms of profitability, RXN's ROE is +0.13%, compared to PCYO's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to PCYO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check PCYO's competition here
RXN vs GWRS Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, GWRS has a market cap of 221.4M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 70.00. In terms of profitability, RXN's ROE is +0.13%, compared to GWRS's ROE of +0.04%. Regarding short-term risk, RXN is more volatile compared to GWRS. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check GWRS's competition here
RXN vs WTRU Comparison April 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRU has a market cap of 0. Regarding current trading prices, RXN is priced at $64.95, while WTRU trades at $53.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRU's P/E ratio is 60.58. In terms of profitability, RXN's ROE is +0.13%, compared to WTRU's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to WTRU. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRU's competition here